Skip to main content

BRIEF-Adamis Pharmaceuticals announces license agreement with Allergan unit

* Watson will obtain commercial rights for U.S. For upfront fee and milestone payments totaling up to $32.5 million
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.